ANCN

Anchiano Therapeutics (ANCN)

Anchiano Therapeutics Ltd

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANCN

1 2 3 4 5 6 Next >>

Date	Time	Source	Headline	Symbol	Company
06/16/2023	4:02PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
06/05/2023	7:01AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
05/19/2023	4:07PM	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
05/11/2023	6:08AM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
03/23/2023	7:37AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
03/23/2023	7:36AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
03/23/2023	7:34AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
03/22/2023	4:46PM	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
02/21/2023	7:06AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
02/21/2023	6:20AM	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
01/11/2023	4:02PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
01/05/2023	4:50PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
01/05/2023	4:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
01/03/2023	7:06AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
11/29/2022	6:17AM	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
11/18/2022	7:54AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
11/17/2022	4:57PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
11/16/2022	7:21AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
11/15/2022	4:04PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
11/14/2022	4:11PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
11/10/2022	4:13PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
08/15/2022	4:07PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
08/12/2022	7:08AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
06/21/2022	7:01AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
06/08/2022	6:03AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
05/31/2022	10:31AM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
05/25/2022	4:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
05/19/2022	4:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
05/12/2022	6:21AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ANCN	Anchiano Therapeutics Ltd
04/28/2022	4:07PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ANCN	Anchiano Therapeutics Ltd